Medflow Scale matches your studies and data to the grants, tenders, and reimbursement you can actually back — every recommendation justified requirement by requirement, and audit-ready. The model proposes; you decide.
Medical-product companies spend years and millions generating evidence — clinical studies, bench data, regulatory files — that then sits idle in PDFs between submissions. The funding and market access it could unlock goes unclaimed, because finding the right opportunities and proving you qualify is manual, consultant-driven, and error-prone. Companies miss what they'd have won, and burn effort on applications they were never eligible for.
Upload the evidence you already have. Scale matches it against a maintained, legally-cleared corpus of opportunities and returns ranked recommendations — each justified requirement by requirement against your own documents.
Scale surfaces the grants, tenders, and reimbursement routes relevant to your sector and technology — from a corpus that's maintained and freshness-monitored.
Your organisation profile and the evidence you hold are mapped to each opportunity's requirements — the system shows exactly what's supported and what's missing.
You review the evidence-backed matches and decide what to pursue. The model proposes; the human acts; the trail is auditable.
The model proposes, the human acts, the trail is auditable. No auto-assertion — a human is always in the loop.
A match earns its place one honest rung at a time — never a pseudo-precise "94% fit."
Matches your sector and technology. (A relevant match never means "you'll win it.")
The hard criteria we can check appear satisfied.
Your documents mapped to the programme's requirements — each one marked:
Legally-cleared and freshness-monitored. A deterministic eligibility gate excludes stale or improper opportunities before ranking.
Every point maps to a visible reason — sector, stage, evidence. No black box, no invented precision.
Every match is bound to the exact evidence and corpus versions used — defensible in a way a generic AI wrapper can't retrofit.
Exportable and deletable, any time. No lock-in.
Non-dilutive innovation funding is large and fragmented across the EU (Horizon Europe, EIC, Eurostars, national funds) and US (SBIR/STTR, NIH) — and the tender and reimbursement layers are larger still.
The architecture is approved; the core database that guarantees tenant isolation, immutability, and audit is built and continuously tested; the product experience is designed and validated; the production build is underway with staging live and disaster-recovery proven. We're building with founding design partners now.
Become a design partner